India  

Hydroxychloroquine

Antimalarial medication

Hydroxychloroquine    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Hydroxychloroquine: Antimalarial medication
Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth. HCQ is being studied to prevent and treat coronavirus disease 2019 (COVID‑19). High-quality evidence of benefit for such use is lacking, with concerns of potential harms from side effects.

0
shares
ShareTweetSavePostSend
 

You Might Like


Back in favour, HCQ could spur India’s Covid-19 diplomacy

With hydroxychloroquine regaining its credibility after WHO restarted its trials and the authors of a Lancet study slamming it falling into controversy, India’s Covid-19 diplomacy, of which supply of..
IndiaTimes - Published

WHO’s stay on HCQ trials was knee-jerk reaction: CSIR chief

A day after the World Health Organisation (WHO) endorsed resuming trials of anti-malarial drug hydroxychloroquine (HCQ) for treatment of Covid-19 patients, chief of Council for Scientific and..
IndiaTimes - Published

HCQ fails to prevent Covid-19 in a rigorous study


IndiaTimes - Published

HCQ and PPE used together cut Covid risk by 80%: ICMR


IndiaTimes - Published

Sustained HCQ intake with PPE use helped prevent Covid-19 in healthcare workers: ICMR study

Sustained intake of anti-malarial drug hydroxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting..
IndiaTimes - Published

Indian scientists including CSIR chief questions the study that prompted WHO to stop HCQ trial


IndiaTimes - Published

Benefits of HCQ outweigh risks, if any: Govt


IndiaTimes - Published

Hydroxychloroquine should be used as per guidelines: Govt

NITI Aayog member (health) and head of Covid-19 medical management empowered group, Dr VK Paul said the findings of studies conducted in India show “benefits of the drug outweigh risks if any” and..
IndiaTimes - Published

Lancet study is not randomised clinical trial, only analysis of hospital registers worldwide: CSIR on WHO suspending HCQ drug testing


IndiaTimes - Published

WHO stops trials, but ICMR says HCQ can be used as preventive drug

A day after the WHO suspended testing of hydroxychloroquine for Covid-19 patients, the Indian Council of Medical Research (ICMR) said the use of the drug as a prophylaxis has been approved based on..
IndiaTimes - Published

Covid-19: India unfazed by HCQ trial halt but will check before donating

While WHO has suspended HCQ trials, stoking further doubts about the efficacy of the drug in dealing with Covid-19, India is unlikely to roll back its medicine diplomacy in haste. The government,..
IndiaTimes - Published

'No harm, potential benefits': ICMR continues recommendation on use of hydroxychloroquine for preventive treatment

Responding to a query on the efficacy of hydroxychloroquine during a media briefing on COVID-19, ICMR chief Balram Bhargava said biological plausibility of HCQ was supporting that it might be an..
DNA - Published

Health ministry asks states/UTs for real-time update of availability and consumption of HCQ


IndiaTimes - Published

ICMR revises guidelines, allows use of HCQ among healthcare workers in COVID-19 containment zones

HCQ can now be administered to all healthcare workers in containment zones; healthcare workers in non-COVID hospitals
DNA - Published

Even those on non-Covid duty now eligible for HCQ


IndiaTimes - Published

After China, India reaches out to LAC, African countries with medicine diplomacy

As China woos the world with Covid-related assistance, India is also looking to spread its medicine diplomacy net far and wide. While many countries like the US have purchased the antimalarial drug —..
IndiaTimes - Published

Centre places orders for 11.45 crore HCQ tablets with 2 Indian firms

India has placed urgent orders for at least 11.45 crore tablets of hydroxychloroquine (HCQ). This drug is being directly procured by HLL Lifecare, on behalf of the Union Health Ministry. Hindustan..
IndiaTimes - Published

States start plasma therapy trials, HCQ administration in War Covid


IndiaTimes - Published

No shortage of Hydroxychloroquine in India: IDMA Gujarat Chairman

The chairman of Indian Drug Manufacturers' Association, Gujarat chapter has asserted that there is no shortage of Hydroxychloroquine in India and the country's current production of HCQ is 35 to 40..
IndiaTimes - Published

Hydroxychloroquine could have side-effects, suggests new study by ICMR

Many healthcare workers who took anti-malaria drug hydroxychloroquine (HCQ) reported side-effects like abdominal pain, nausea and hypoglycemia during a study conducted by the Indian Council of Medical..
IndiaTimes - Published

Eternally grateful for quick HCQ delivery: Dominican Republic


IndiaTimes - Published

MEA pulled out all stops to send HCQ to Dominican Republic

India this week managed to send an emergency aid comprising 200,000 HCQ tablets to Dominican Republic (DR) located in the Caribbean. After exploring several options unsuccessfully, the MEA got the..
IndiaTimes - Published

Covid-19: Maharashtra may hand out anti-malaria drug as preventive med

The Maharashtra government is considering giving hydroxychloroquine sulphate (HCQS) tablets as a "preventive medicine" to slum residents at highest risk of the infection. A high-ranking state..
IndiaTimes - Published

COVID-19: India clears first list of 13 nations for hydroxychloroquine export; neighbouring countries get priority

The HCQ, termed as a game-changer drug by India, will be provided to 13 countries. The countries are listed here:
DNA - Published

HCQ supply doubled in domestic market to prevent hoarding

Addressing reports of shortage, government officials said there were sufficient stocks of HCQ in the country to meet demand and also for a buffer. The government estimates that India needs 1.6 crore..
IndiaTimes - Published

Will aid humanity’s fight, says PM Modi after Donald Trump’s ‘thanks’

The exchange between PM Modi and President Trump comes just days after certain comments by Trump had been construed to appear like he was threatening retaliation if New Delhi didn’t lift the export..
IndiaTimes - Published